Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Folate, B Vitamins Reduce Homocysteine Levels, But Not CVD Risk – NEJM

This article was originally published in The Tan Sheet

Executive Summary

Results from two recent studies on reduction of homocysteine with B vitamins and folic acid may lead to a reexamination of the hypothesis that lowering homocysteine levels reduces the risk for cardiovascular disease

You may also be interested in...



Folic Acid Does Prevent Strokes, Lancet Meta-Analysis Says

Folic acid supplementation reduces the risk of stroke by 25 percent over placebo in populations where folate fortification of grains is not required, whereas in countries with required fortification, the risk was reduced by 11 percent, according to a Lancet meta-analysis published June 2

Folic Acid Does Prevent Strokes, Lancet Meta-Analysis Says

Folic acid supplementation reduces the risk of stroke by 25 percent over placebo in populations where folate fortification of grains is not required, whereas in countries with required fortification, the risk was reduced by 11 percent, according to a Lancet meta-analysis published June 2

Folic Acid Does Prevent Strokes, Lancet Meta-Analysis Says

Folic acid supplementation reduces the risk of stroke by 25 percent over placebo in populations where folate fortification of grains is not required, whereas in countries with required fortification, the risk was reduced by 11 percent, according to a Lancet meta-analysis published June 2

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel